Skip to main content
. Author manuscript; available in PMC: 2019 Apr 18.
Published in final edited form as: J Hepatol. 2018 Aug 21;69(6):1317–1325. doi: 10.1016/j.jhep.2018.08.004

Figure 1-. Overview of study cohort.

Figure 1-

Among 1786 cases of suspected drug-induced liver injury enrolled in the DILIN between September 2004 and February 2017, 1549 underwent formal causality assessment by the time of formal analysis, of which 1260 cases were judged to be definite, highly likely or probable; 15 of these (1.2%) were attributed to terbinafine.